key: cord-0740590-dh72u73d
authors: Doyle, Máire E.; Appleton, Ashley; Liu, Qing-Rong; Yao, Qin; Mazucanti, Caio Henrique; Egan, Josephine M.
title: Human Type II Taste Cells Express ACE2 and are Infected by SARS-CoV-2
date: 2021-06-06
journal: Am J Pathol
DOI: 10.1016/j.ajpath.2021.05.010
sha: b07550ef9d911704de3082cafd41aea3bb306336
doc_id: 740590
cord_uid: dh72u73d

Chemosensory changes are well-reported symptoms of SARS-CoV-2 infection. The virus targets cells for entry by binding of its spike protein to cell-surface angiotensin-converting enzyme- 2 (ACE2). It was not known whether ACE2 is expressed on taste receptor cells (TRCs) nor if TRCs are infected directly. Using an in-situ hybridization (ISH) probe and an antibody specific to ACE2, ACE2 is present on a subpopulation of TRCs, namely, Type II cells in taste buds in taste papillae. Fungiform papillae (FP) of a SARS-CoV-2+ patient exhibiting symptoms of COVID-19, including taste changes, were biopsied. Based on ISH, replicating SARS-CoV-2 was present in Type II cells. Therefore, taste Type II cells provide a potential portal for viral entry that predicts vulnerabilities to SARS-CoV-2 in the oral cavity. The continuity and cell turnover of the patient’s FP taste stem cell layer were disrupted during infection and had not completely recovered 6 weeks post symptom onset. Another patient suffering post-COVID-19 taste disturbances also had disrupted stem cells. These results demonstrate the possibility that novel and sudden taste changes frequently reported in COVID-19 may be the result of direct infection of taste papillae by SARS-CoV-2. This may result in impaired taste receptor stem cell activity and suggest more work is needed to understand the acute and post-acute dynamics of viral kinetics in the human taste bud.

As many as 80% of people infected with SARS-CoV-2 report taste and smell changes, as well as changes in overall oral sensitivity to commonly used condiments and spices 1 . The constellation of sensory symptoms can precede systemic symptoms and therefore has predictive value. 2, 3 Interestingly, RNA for SARS-CoV-2 was detected in the submandibular glands and tumor of a patient undergoing tongue surgery for squamous carcinoma two days before the patient developed symptoms and had a positive nasal swab for the virus: 4 however, taste tissue was not examined. The sensory symptoms need not be unitary as the virus can independently target all or any combination of the senses 5, 6 and may even cause deficits or changes in a specific taste quality. Branches of five cranial nerves (CN I [smell], V [chemesthesis: heat, pungency], and VII, IX and X [taste, Figure 1A ] are involved in relaying those specific senses to the central nervous system. Taste is first discriminated in taste receptor cells (TRCs) within taste buds, which are autonomous organs mostly located in circumvallate (CV), foliate (FL), and fungiform (F) papillae (P) in the tongue. Each taste bud is supplied by nerve fibers, a capillary artery and vein. Solitary taste buds are also buried in the epithelial layer of the uvula, epiglottis, larynx, upper airways and proximal esophagus. TRCs contain the machinery for discriminating five prototypic tastes that can be appreciated from commonly consumed foods: salty (pretzels), sweet (chocolate, sugar, artificial sweeteners), bitter (coffee), umami (monosodium glutamate, sweet amino acids) and sour (citrus); one, more than one or all may be altered (dysgeusia) or absent (ageusia) due to SARS-CoV-2 infection.

Taste buds contain just three distinct types of TRCs for mediating taste discrimination: Type I (salty), Type II (sweet, bitter and umami; these are discriminated on the basis of specific receptor engagement on the cell surface while sharing downstream signal transduction mechanisms) and Type III (sour) ( Figure 1A) . 7, 8 Solitary chemosensory cells containing similar bitter receptors and signal transduction machinery as are present in Type II cells reside in trachea, extrapulmonary bronchi and in the lung hilus, where based on rodent investigations they 'sense' the microenvironment and regulate respiration rate through CN X; bitter stimuli and J o u r n a l P r e -p r o o f cholinergic activation lead to decreased respiratory rates. 9 All taste buds have the same three TRC types, though ratios of cell types vary ( Figure 1A ). For example, Type I cells are rare in FP. 10 These TRCs are not neurons: they are modified epithelial cells. ACE2 expression has not been found in the neurons of the geniculate ganglion 11, 12 whose fibers innervate the FP via CN VII, or in sensory afferents of CN X 13 that innervate the solitary buds of the epiglottis, larynx, and chemosensory cells of the airways. Additionally, CN V neurons, which mediate chemesthesis, do not express ACE2. 14, 15 It therefore seemed unlikely that alterations in taste and chemesthesis are due to SARS-CoV-2 invasion of sensory afferents of four CNs, but more likely due to direct infection of the taste buds, lingual epithelium and oral mucosa. Epithelial cells shed into saliva, the source of which could be lingual epithelium, salivary glands and oral mucosal surfaces, from SARS-CoV-2 infected patients were recently reported to contain low ACE2 expression, and in some cases, viral RNA. 16 TRCs or chemosensory cells were not studied in that report. Here we demonstrate using two highly specific techniques, in-situ hybridization (ISH) probe and an antibody specific to ACE2, that ACE2 is present on a subpopulation of specialized TRCs, namely, PLCβ 2 positive, Type II cells in taste buds in taste papillae and that these Type II cells are also infected with SARS-CoV-2.

Human circumvallate papillae (CVP) tissue was obtained from cadaveric tongues and placed in formalin 

CVP tissue and FP were cryosectioned (10 µm thick) using a Leica CM 1950 cryostat, mounted onto ColorFrost Plus Micro slides (Fisher Scientific) and then stored at -80°C. Immunostaining was performed as described previously. 10 To permeabilize the cells in the tissue, slides were placed in Tris-buffered saline (TBS) (pH, 7.4; Quality Biologicals, Gaithersburg, MD) with 0.2% Triton-X 100 (Millipore Sigma) for 5 minutes at room temperature. They were then washed three times (2 minutes) in TBS. Antigen retrieval was performed by placing the slides in 10 mM of sodium citrate buffer (pH, 6.0; Vector Laboratories, Burlingame, CA) at 95°C for 30 minutes. The slides were left to cool at room temperature in the citrate buffer for a further 30 minutes and were then rinsed in water and then TBS as before. Sections were incubated with normal goat serum block consisting of 2% goat serum, 1% OmniPur BSA Fraction V (Millipore Sigma), 0.1% gelatin, (Millipore Sigma), 0.1% Triton X-100 (Millipore Sigma), 0.05% Tween 20 (Millipore Sigma), and 0.05% sodium azide (Millipore Sigma) in TBS for 1 hour at room temperature. Sections were then incubated with primary antibodies (Table   1 [17] [18] [19] ) diluted in the same normal goat serum block at 4°C overnight. Tissue sections were rinsed with TBS with 5% tween (TBST) and incubated for 1 hour with fluorescently labelled secondary antibodies (Table 1) RNAscope probes were all from Advanced Cell Diagnostics (Newark, CA; Table 2 ). V-nCoV2019-S (Cat# 848561) is an antisense probe specific to the viral genomic positive strand RNA of the spike protein sequence and V-nCoV2019-orf1ab (Cat# 859151) is a sense probe specific to the viral ORF1ab (Open Reading Frame 1ab) negative strand RNA produced when the virus is replicating 20 . Taste receptor cell marker probe for Type I cell was ENTPD2 (Cat# 507941), for Type II cell was PCLB2 (custom designed), and Type III cell was NCAM1 (Cat# 421468). ENTPD2 is translated into ectonucleoside triphosphate diphosphohydrolase 2 which is expressed only on Type I cells, 21 while NCAM1 is translated to a neural cell adhesion molecule that is a cell surface marker for Type III cells. 22 

Humans have approximately 5,000-10,000 taste buds, of which about half are buried on the sides of CVP ( Figure 1A , B). 23 The presence of ACE2 in taste buds within CVP of post-mortem tissue was investigated by immunofluorescent staining (IFS) and found it to be co-expressed with phospholipase C β 2 (PLCβ 2 ), a marker and obligatory signal transduction molecule in Type II TRCs ( Figure 1B , top panel) 24 . Taste buds within FLPs, which are vertical folds on the sides of the tongue, were not sufficiently preserved for definitive ACE2 IFS. Figure 2F .

We discovered that oral infection and replication with SARS-CoV-2 occurred in taste bud Type II cells. Virus may be transported to the oral cavity on air eddies containing virus in droplets directly into mouth and/or in droplets, nasal mucous or epithelial cells shed from the nose ( Figure 1A) . While SARS-CoV-2 infection is noted in oral cavity, in salivary glands, gingiva, oral mucosa and saliva 16 , no one has yet published on taste tissue. Furthermore, previous studies 16, 26, 27 did not address the cellular location of ACE2 within human taste buds using the highly specific techniques of ISH (mRNA) and IFS (protein). Taste buds do not contain a resident immune system 28 The presence of ACE2 on Type II cells specifically is very intriguing because these are the cells that 'taste' amino acids and ACE2 in the gut has been shown to dimerize with amino acid transporters where it plays a vital role in efficient amino acid absorption. 34 We hypothesize that ACE2 is also on the chemosensory cells present in airways as their cellular machinery is similar to Type II cells in taste buds. They contain bitter receptors activated by ligands such cycloheximide, a bitter receptor agonist, and require PLCβ 2 for signal transduction. 9 Therefore, viral infection of those cells might directly decrease respiratory drive, resulting in worsening oxygen desaturation. The role of chemosensory cells in the upper airways or of TRCs in taste buds during SARS-CoV-2 infection has not been studied because of practical difficulties: obtaining a fresh CVP where numerous taste buds reside and where they are larger than in FP is not a viable option because CVPs have not been shown to regrow 35 ; obtaining FP or especially fresh tissue from airways in sick people has associated medical conundrums; there is a paucity of taste buds within FP as there are at most two taste buds but sometimes just one and occasionally none, even in young people 36 ; taste buds may be damaged by virus and not J o u r n a l P r e -p r o o f be recognizable, especially to an untrained eye; taste buds are buried in the epithelial layer where they occupy less than 1% of the total mass of a papilla ( Figure 1A , B) and therefore are easily missed if the whole papilla is not systematically sectioned; and finally, even when present, a taste bud in a FP is approximately 30 µm in diameter, thereby providing a maximum of 3-4 slides with taste bud cells for in depth investigation. This had led to the weakness of the study -we had one FP containing taste buds from one participant in which to study the acute effects of the virus.

In 

Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients

Real-time tracking of self-reported symptoms to predict potential COVID-19

Hypogeusia as the initial presenting symptom of COVID-19

SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma

Sensitivity and specifity of prediction models based on gustatory disorders in diagnosing COVID-19 patients: a case-control study

More Than Smell-COVID-19 Is Associated With Severe Impairment of Smell, Taste, and Chemesthesis

Recent advances in taste transduction and signaling

Taste buds: cells, signals and synapses

Cholinergic chemosensory cells in the trachea regulate breathing

Transcriptomes and neurotransmitter profiles of classes of gustatory and somatosensory neurons in the geniculate ganglion

Sour Sensing from the Tongue to the Brain

An Airway Protection Program Revealed by Sweeping Genetic Control of Vagal Afferents

Stereotyped transcriptomic transformation of somatosensory neurons in response to injury

Diversity amongst trigeminal neurons revealed by high throughput single cell sequencing

SARS-CoV-2 infection of the oral cavity and saliva

Broad transcriptional dysregulation of brain and choroid plexus cell types with COVID-19

Olfactory transmucosal SARS-CoV-2 invasion as port of Central Nervous System entry in COVID-19 patients

Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens

Role of the ectonucleotidase NTPDase2 in taste bud function

Mash1-expressing cells could differentiate to type III cells in adult mouse taste buds

Anatomy and development of the human taste system

G protein betagamma complexes in circumvallate taste cells involved in bitter transduction

Functional cell types in taste buds have distinct longevities

ACE2 and Furin Expressions in Oral Epithelial Cells Possibly Facilitate

Infection via Respiratory and Fecal-Oral Routes. Frontiers in medicine

Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity

SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done? Immunity & ageing : I & A 2020

Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia

Absent Blood Oxygen Level-Dependent Functional Magnetic Resonance Imaging Activation of the Orbitofrontal Cortex in a Patient With Persistent Cacosmia and Cacogeusia After

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

The endocrinology of taste receptors

ACE2 and gut amino acid transport

Regeneration of taste buds after surgical excision of human vallate papilla

Fine structure of taste buds in the human fungiform papilla

Post-acute COVID-19 syndrome

Persistent Symptoms in Patients After Acute COVID-19

Follow-up of adults with noncritical COVID-19 two months after symptom onset

Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort

Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study

Hypogeusia, dysgeusia, hyposmia, and dysosmia following influenzalike infection. The Annals of otology, rhinology, and laryngology

All authors contributed equally. We thank all the participants of the study (2018-AG-N010) and all the IRP NIA clinical staff.

J o u r n a l P r e -p r o o f